Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Jones

Showing results (71-80 of 945) with videos related to

Pageof 95
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 9, 2008
Key considerations in the treatment of complicated staphylococcal infectionsR N Jones
Diagnostic Microbiology and Infectious Disease|July 1, 1989
Should novobiocin be clinically re-evaluated?R N Jones
Infection|January 1, 1994
The antimicrobial activity of cefotaxime: comparative multinational hospital isolate surveys covering 15 yearsR N Jones
The Journal of Antimicrobial Chemotherapy|March 1, 1991
Activity of sparfloxacin (AT-4140), PD127391 and PD131628 against Legionella sppR N Jones
Drugs|January 1, 1995
In vitro antimicrobial activity of CP-99,219, a new 7-azabicyclonaphthyridoneR N Jones
The Journal of Reproductive Medicine|June 1, 1988
Implications of beta-lactamase-inhibitor combinationsR N Jones
The American Journal of Medicine|June 30, 1986
In vitro evaluations of amikacin: an assessment of the currently used methods of disk diffusion and dilution susceptibility, antimicrobial synergy, and the measurement of amikacin concentrationsR N Jones
JAMA|April 25, 1977
Respiratory health and polyvinyl chloride fumesR N Jones, H Weill
Diagnostic Microbiology and Infectious Disease|July 1, 1991
In vitro activity of 43 antimicrobial agents tested against ampicillin-resistant enterococci and gram-positive species resistant to vancomycinN Yamane, R N Jones
Reviews of Infectious Diseases|September 1, 1982
Cefotaxime: a review of in vitro antimicrobial properties and spectrum of activityR N Jones, C Thornsberry
Pageof 95

Showing results (71-80 of 945) with videos related to

Sort By:
Pageof 95
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 9, 2008
Key considerations in the treatment of complicated staphylococcal infectionsR N Jones
Diagnostic Microbiology and Infectious Disease|July 1, 1989
Should novobiocin be clinically re-evaluated?R N Jones
Infection|January 1, 1994
The antimicrobial activity of cefotaxime: comparative multinational hospital isolate surveys covering 15 yearsR N Jones
The Journal of Antimicrobial Chemotherapy|March 1, 1991
Activity of sparfloxacin (AT-4140), PD127391 and PD131628 against Legionella sppR N Jones
Drugs|January 1, 1995
In vitro antimicrobial activity of CP-99,219, a new 7-azabicyclonaphthyridoneR N Jones
The Journal of Reproductive Medicine|June 1, 1988
Implications of beta-lactamase-inhibitor combinationsR N Jones
The American Journal of Medicine|June 30, 1986
In vitro evaluations of amikacin: an assessment of the currently used methods of disk diffusion and dilution susceptibility, antimicrobial synergy, and the measurement of amikacin concentrationsR N Jones
JAMA|April 25, 1977
Respiratory health and polyvinyl chloride fumesR N Jones, H Weill
Diagnostic Microbiology and Infectious Disease|July 1, 1991
In vitro activity of 43 antimicrobial agents tested against ampicillin-resistant enterococci and gram-positive species resistant to vancomycinN Yamane, R N Jones
Reviews of Infectious Diseases|September 1, 1982
Cefotaxime: a review of in vitro antimicrobial properties and spectrum of activityR N Jones, C Thornsberry
Pageof 95